Researchers found that 8.3% of US adults had at least one major depressive episode. In adolescents, the rate was 20.1%, with 29.2% of female adolescents reporting a major depressive episode. Major ...
The US FDA has approved lumateperone (Caplyta, Johnson & Johnson) for use as adjunctive therapy with antidepressants for the treatment of adults with major depressive disorder (MDD). The approval of ...
Stress gets blamed for a lot of things. Did you gain a few pounds? Blame stress. Say something you regret. Blame stress. But what about something more serious like major depressive disorder? Stress ...